Poppe, D; Tiede, I; Fritz, G et al.
Azathioprine suppresses ezrin-radixin-moesin-dependent T cell-APC conjugation through inhibition of Vav guanosine exchange activity on Rac proteins.J Immunol. Bd. 176. H. 1. 2006 S. 640-51
Christmann, M; Tomicic, MT; Origer, D et al.
c-Fos is required for excision repair of UV-light induced DNA lesions by triggering the resynthesis of XPFNucleic Acids Res. Bd. 34. 2006 S. 6530-6539
Hausherr, CK; Schiffer, IB; Gebhard, S et al.
Dephosphorylation of p-ERK1/2 in relation to tumor remission after HER-2 and Raf1 blocking therapy in a conditional mouse tumor modelMol Carcinog. Bd. 45. H. 5. 2006 S. 302-308
Roos, WP; Kaina, B
DNA damage-induced cell death by apoptosisTrends in Molecular Medicine. Bd. 12. H. 9. 2006 S. 440-450
Kaina, B; Fritz, G
DNA Damaging AgentsGanten (Hrsg). Encyclopedic Reference of Genomic and Proteomics in Molecular Medicine. Springer Verlag 2006
Albrich, SB; Bremer, E; Schmidt, M et al.
Einfluss von HER-2 und Topoisomerase II-alpha auf die ex vivo Chemosensitivität für Epirubicin beim primären MammakarzinomGeburtshilfe Frauenheilkd. Bd. 67. 2006 S. (S1)
Spangenberg, C; Lausch, EU; Trost, TM et al.
ERBB2-mediated transcriptional up-regulation of the alpha5beta1 integrin fibronectin receptor promotes tumor cell survival under adverse conditionsCancer Res. Bd. 66. 2006 S. 3715-3725
Carmo, H; Brulport, M; Hermes, M et al.
Influence of CYP2D6 polymorhpism on 3,4-methylenedioxymethamphetamine (Ecstasy) cytotoxicityPharmacogenet Genomics. 2006 S. 789-799
Fritz, G; Kaina, B
Late activation of stress kinases (SAPK/JNK) by genotoxins requires the DNA repair proteins DNA-Pkcs and CSBMol Cell Biol. Bd. 17. 2006 S. 851-861
Nubel, T; Damrot, J; Roos, WP et al.
Lovastatin protects human endothelial cells from killing by ionizing radiation without impairing induction and repair of DNA double-strand breaks.Clin Cancer Res. Bd. 12. H. 3 Pt 1. 2006 S. 933-9
Damrot, J; Nubel, T; Epe, B et al.
Lovastatin protects human endothelial cells from the genotoxic and cytotoxic effects of the anticancer drugs doxorubicin and etoposide.Br J Pharmacol. Bd. 149. H. 8. 2006 S. 988-97
Hermisson, M; Klumpp, A; Wick, W et al.
O6-methylguanine DNA methyltransferase and p53 status predict temozolomide sensitivity in human malignant glioma cells.J Neurochem. Bd. 96. H. 3. 2006 S. 766-76
Kaina, B; Christmann, M
O6-Methylguanine-dNA methyltransferases (alkyltransferases)Ganten (Hrsg). Encyclopedic Reference of Genomic and Proteomics in Molecular Medicine. Springer-Verlag 2006
Hengstler, J. G.; Bockamp, E. O.; Hermes, M. et al.
Oneogene-blocking therapies: New insights from conditional mouse tumor modelsCURRENT CANCER DRUG TARGETS. Bd. 6. H. 7. 2006 S. 603-612
McGurk, CJ; Cummings, M; Koberle, B et al.
Regulation of DNA repair gene expression in human cancer cell lines.J Cell Biochem. Bd. 97. H. 5. 2006 S. 1121-36
Fritz, G; Kaina, B
Rho GTPases: promising cellular targets for novel anticancer drugs.Curr Cancer Drug Targets. Bd. 6. H. 1. 2006 S. 1-14
Vodicka, P; Koskinen, M; Naccarati, A et al.
Styrene metabolism, genotoxicity and potential carcinogenicityDrug Metab Rev. Bd. 38. 2006 S. 805-53
Muhlhausen, U; Schirrmacher, R; Piel, M et al.
Synthesis of 131I-labeled glucose-conjugated inhibitors of O6-methylguanine-DNA methyltransferase (MGMT) and comparison with nonconjugated inhibitors as potential tools for in vivo MGMT imaging.J Med Chem. Bd. 49. H. 1. 2006 S. 263-72
Bockamp, Ernesto; Antunes, Cecilia; Maringer, Marko et al.
Tetracycline-controlled transgenic targeting from the SCL locus directs conditional expression to erythrocytes, megakaryocytes, granulocytes, and c-kit-expressing lineage-negative hematopoietic cellsBLOOD. Bd. 108. H. 5. 2006 S. 1533-1541
Schmidt, S; Debensason, D; Mühlan, H et al.
The DISABKIDS generic quality of life instrument showed cross-cultural validity.J Clin Epidemiol. Bd. 59. H. 6. 2006 S. 587-98
Schmidt, S; Mühlan, H; Power, M
The EUROHIS-QOL 8-item index: psychometric results of a cross-cultural field study.Eur J Public Health. Bd. 16. H. 4. 2006 S. 420-8
Köberle, B; Roginskaya, V; Wood, RD
XPA protein as a limiting factor for nucleotide excision repair and UV sensitivity in human cells.DNA Repair (Amst). Bd. 5. H. 5. 2006 S. 641-8
Cummings, M; Higginbottom, K; McGurk, CJ et al.
XPA versus ERCC1 as chemosensitising agents to cisplatin and mitomycin C in prostate cancer cells: role of ERCC1 in homologous recombination repair.Biochem Pharmacol. Bd. 72. H. 2. 2006 S. 166-75
Tsaryk, R; Fabian, K; Thacker, J et al.
XRCC2 deficiency sensitizes cells to apoptosis by MNNG and the alkylating anticancer drugs temozolomide, fotemustine and mafosfamideCancer Lett. Bd. 239. 2006 S. 305-313
Holtmann, M; Kaina, B; Poustka, F
Zytogenetische Veränderungen durch Methylphenidat?Z Kinder Jugendpsychiatr Psychother. Bd. 34. 2006 S. 215-220